FDA psychedelics; DE marijuana rules; NY homegrow; SD cannabis worker protections gutted; NJ $1B projection; NM psilocybin; FL potency cap
Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day.
Your support makes Marijuana Moment possible…
Before you dig into today’s cannabis news, I wanted you to know you can keep this resource free and published daily by subscribing to Marijuana Moment on Patreon. We’re a small independent publication diving deep into the cannabis world and rely on readers like you to keep going.
Join us at https://www.patreon.com/marijuanamoment
/ TOP THINGS TO KNOW
Vice President Kamala Harris’s office is actively reaching out to cannabis clemency recipients, an activist who had a meeting with three staffers about his pardon certificate experience told Marijuana Moment.
Food and Drug Administration officials participated in a psychedelics research event, with the head of the agency’s Center for Drug Evaluation and Research calling it an opportunity to “expand our knowledge about psychedelic clinical trial design.”
The Delaware Office of the Marijuana Commissioner posted an initial set of draft regulations for the adult-use cannabis market.
The New York Cannabis Control Board approved draft rules allowing
Read full article on Marijuana Moment
